Related Experiment Video
Updated: May 12, 2026
10:19
High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
[Autoantibody diagnostics in neurology using native and recombinant antigenic substrates]
W Stöcker1, S Saschenbrecker, K Rentzsch
1Institut für Experimentelle Immunologie, Euroimmun, Seekamp 31, 23560 Lübeck, Deutschland. w.stoecker@euroimmun.de
Der Nervenarzt
|April 10, 2013
Summary
Modern diagnostics detect neurologically relevant autoantibodies using tissue sections and transfected cells. Parallel analysis of all major antineural autoantibodies is recommended for accurate diagnosis, especially for cell surface antibodies like those against NMDA receptors.
Area of Science:
- Neurology
- Immunology
- Diagnostics
Context:
- Current methods for detecting neurologically relevant autoantibodies rely on indirect immunofluorescence with tissue sections.
- Human embryonic kidney (HEK) cells transfected with neurological antigens enable monospecific detection.
- Biochip mosaics offer a rapid overview of multiple analytes, while Western and line blots provide further characterization.
Purpose:
- To outline modern diagnostic approaches for autoantibodies in neurological diseases.
- To emphasize the importance of comprehensive autoantibody screening over single-parameter tests.
- To highlight the shift towards detecting antibodies against neural cell surface structures, particularly NMDA receptors.
Summary:
- Neurological autoantibody diagnostics utilize indirect immunofluorescence, transfected HEK cells, biochip mosaics, and Western/line blots.
- Comprehensive parallel analysis of various antineural autoantibodies is crucial for accurate diagnosis.
- Antibodies targeting neural cell surface structures, such as NMDA receptors, are increasingly prevalent.
Impact:
- Facilitates more accurate and efficient diagnosis of autoimmune neurological disorders.
- Guides clinicians towards a broader diagnostic strategy, improving patient outcomes.
- Advances understanding of autoimmune mechanisms in neurological conditions, particularly those involving cell surface targets.
